z-logo
Premium
Effects of enzastaurin and its metabolites on the QT interval in cancer patients
Author(s) -
Welch Pamela A.,
Ng Wee Teck,
Darstein Christelle L.,
Musib Luna,
Lesimple Thierry
Publication year - 2016
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/jcph.573
Subject(s) - qt interval , medicine , cmax , torsades de pointes , dofetilide , pharmacology , pharmacokinetics , moxifloxacin , clinical pharmacology , cardiology , chemistry , biochemistry , antibiotics
Preclinical and interim results from a clinical pharmacology study in patients with cancer indicated that enzastaurin might have the potential to prolong the QT. Rather than undertake a formal thorough QT study, the effect of enzastaurin on the QT was assessed by combining the QT corrected for heart rate (QTc) intervals from 3 clinical pharmacology studies totaling 85 patients with cancer receiving multiple therapeutic or supratherapeutic doses of enzastaurin. Neither a placebo nor an active control was used. Serial, replicate, time‐matched electrocardiograms were collected during a no‐drug baseline day and when enzastaurin and its major active metabolite, LSN326020, had achieved steady state. Plasma concentrations of enzastaurin and LSN326020 were determined at each electrocardiogram point to enable concentration–QT analyses. The cross‐study analysis showed that enzastaurin resulted in a statistically significant prolongation of the QTc at therapeutic and supratherapeutic doses. At an enzastaurin maximum plasma concentration (C max ) of 3660 nmol/L, the predicted QTc using Fridericia's formula (QTcF) interval and its 90% confidence interval was 17.72 milliseconds (16.52–18.92 milliseconds). Likewise, at an LSN326020 C max value of 1718 nmol/L, the predicted QTcF interval was 20.23 milliseconds (18.72–21.74 milliseconds). The concentration–QTcF slopes for enzastaurin and LSN326020 were positive and statistically significantly different from zero (all P < .05).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here